Viking Therapeutics
VKTX
VKTX
114 hedge funds and large institutions have $76.5M invested in Viking Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 43 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
42% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 43
57% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 42
Holders
114
Holding in Top 10
–
Calls
$1.49M
Puts
$311K
Top Buyers
| 1 | +$7.64M | |
| 2 | +$3.83M | |
| 3 | +$955K | |
| 4 |
Morgan Stanley
New York
|
+$881K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$875K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$3.17M | |
| 3 | -$1.75M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$1.51M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.42M |